Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Current Oncology (Toronto, Ont.)|March 26, 2025
Influence of Vitamin D and Its Analogues in Type-B LymphomasValerio Basile, Alessandro Allegra, Herbert Ryan Marini, et al.
Molecular Cancer|February 20, 2018
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemiaMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Plos One|July 12, 2014
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patientsCesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, et al.
BMC Cancer|February 7, 2013
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferationCesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Acta Oncologica (Stockholm, Sweden)|March 25, 2010
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsFabio Stagno, Paolo Vigneri, Vittorio Del Fabro, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 PandemicStefania Stella, Silvia Rita Vitale, Michele Massimino, et al.
Oncology Letters|August 13, 2019
Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 <i>BCR-ABL1</i> fusion transcript: A case reportMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Anticancer Research|July 3, 2019
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 <i>Bcr-Abl1</i> Fusion Transcript: A Case ReportMichele Massimino, Stefania Stella, Elena Tirrò, et al.
European Journal of Haematology|January 5, 2011
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cellsCesarina Giallongo, Piera La Cava, Daniele Tibullo, et al.
Oncotargets and Therapy|October 9, 2023
High <i>BCR::ABL1</i> Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal AbilityMichele Massimino, Stefania Stella, Elena Tirrò, et al.
Pageof 14